Orexigen Therapeutics, Inc. (NASDAQ:OREX) - Page 2

Bull and Bear

Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More

Stocks have marginally pulled back from their all-time highs early this week. Investors are being told over and over the raging bull market has changed into a stock picker's market ...
Read Full Story »
153576724

Orexigen Irony: No VIVUS Bounce

VIVUS Inc. (NASDAQ: VVUS) investors have a lot to be disappointed about these days. America's ballooning waistline is reaching a critical level, yet VIVUS did not even manage to close ...
Read Full Story »
research

Piper Jaffray’s Seven Biotech Stocks to Buy With Huge Potential Upside

Once again, the analysts at Piper Jaffray are conducting extensive management meetings with the companies they cover. Investors looking for top names to buy now may be at the right ...
Read Full Story »
2014 in the box

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

All of the major firms on Wall Street we cover have prognostications and stock picks for 2014. The Cowen biotechnology team has a list of top 10 surprises that are ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: BlackBerry, Micron, SanDisk, VIVUS and More

With the government shut down and with the debt ceiling debate breathing down everyone's neck, investors have to be wondering what they should buy, sell and hold (or even avoid). ...
Read Full Story »
131772836

Analysts See Big Upside in 10 Stocks to Buy Under $10

As a rule, Wall Street brokers and financial advisors typically try to steer their clients away from stocks that trade under $10, as well as avoid like the plague stocks ...
Read Full Story »
biotech

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

The higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios. With the market currently teetering on ...
Read Full Story »
pills

Arena Withdraws Application for Weight-Loss Drug Approval in Europe

Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) has withdrawn its application for European regulatory approval of its weight-loss drug Belviq. The drug was approved for use in the United States ...
Read Full Story »
biotech

Top Biotech-Pharma Stock Ideas With Continued Big Upside (OREX, HALO, BAX, BMRN)

Much of the research coverage on Wall St. from the bulge bracket firms is concentrated on the most liquid, best known stocks from the S&P 500. These names are recognizable ...
Read Full Story »
76764023

VIVUS Obesity Drug Sales Only About 60% of Expectations

VIVUS Inc. (NASDAQ: VVUS) reported a quarterly loss of $0.56 per share on Monday, but this was not an earnings story. VIVUS remains a developing story about its obesity drug ...
Read Full Story »
76764023

Europe Denies Obesity Drug Approval

If you are obese in Europe, you are not about to get a little pill to take to help you change. You will just have to lose that weight the old-fashioned ...
Read Full Story »
76764023

Positive Clinical Study Could Provide a Tailwind for Obesity Drugs (VVUS, ARNA, OREX)

According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese or very overweight. Obesity-related medical conditions include heart attack, ...
Read Full Story »
76764023

Arena Risk: Possible Drag on All Weight-Loss Drugs

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) is posing yet one more threat to ambitious biotechs and drug-makers who are targeting the obesity market. Its stock is getting slapped by almost 10% ...
Read Full Story »
76764023

The Obesity Drug Stock Rally Has Started (OREX, ARNA, VVUS, BAC)

Back in December, we took an in-depth look at what has become a crowded race in the obesity drug market. As we pointed out then, the race has become a ...
Read Full Story »
76764023

Is There Finally a Winner in the Crowded Obesity Drug Market?

According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke, type-2 diabetes ...
Read Full Story »